Epidemiology of invasive pulmonary aspergillosis

Aspergillosis: From Diagnosis to Prevention

Volumn , Issue , 2010, Pages 329-344

  Kauffman, Carol A ^a   Nicolasora, Nelson P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Epidemiology; Haematological malignancy; Haematopoietic stem cell transplant; Invasive aspergillosis

Indexed keywords

EID: 84864426178     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-2408-4_20     Document Type: Chapter

References (93)

1. Baddley, J. W., Stroud, T. P., Salzman, D. & Pappas, P. G. (2001) Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis, 32, 1319-24.
2. Boutboul, F., Alberti, C., Leblanc, T., Sulahian, A., Gluckman, E., Derouin, F. & Ribaud, P. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis, 34, 939-43.
3. Cornet, M., Fleury, L., Maslo, C., Bernard, J. F. & Brucker, G. (2002) Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect, 51, 288-96.
4. De La Rosa, G. R., Champlin, R. E. & Kontoyiannis, D. P. (2002) Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients. Transpl Infect Dis, 4, 3-9.
5. Dykewicz, C. A. (2001) Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis, 33, 139-44.
6. Marr, K. A., Carter, R. A., Boeckh, M., Martin, P. & Corey, L. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood, 100, 4358-66.
7. Ribaud, P., Chastang, C., Latge, J. P., Baffroy-Lafitte, L., Parquet, N., Devergie, A., Esperou, H., Selimi, F., Rocha, V., Derouin, F., Socie, G. & Gluckman, E. (1999) Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis, 28, 322-30.
8. Wald, A., Leisenring, W., Van Burik, J. A. & Bowden, R. A. (1997) Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis, 175, 1459-66.
9. Jantunen, E., Nihtinen, A. & Anttila, V. J. (2008) Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients. Transpl Infect Dis, 10, 156-61.
10. Marr, K. A., Carter, R. A., Crippa, F., Wald, A. & Corey, L. (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis, 34, 909-17.
11. Cordonnier, C., Ribaud, P., Herbrecht, R., Milpied, N., Valteau-Couanet, D., Morgan, C. & Wade, A. (2006) Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. Clin Infect Dis, 42, 955-63.
12. Lin, S. J., Schranz, J. & Teutsch, S. M. (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis, 32, 358-66.
13. Singh, N. & Paterson, D. L. (2005) Aspergillus infections in transplant recipients. Clin Microbiol Rev, 18, 44-69.
14. Baddley, J. W., Pappas, P. G., Smith, A. C. & Moser, S. A. (2003) Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol, 41, 5525-9.
15. Morgan, J., Wannemuehler, K. A., Marr, K. A., Hadley, S., Kontoyiannis, D. P., Walsh, T. J., Fridkin, S. K., Pappas, P. G. & Warnock, D. W. (2005) Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol, 43(Suppl 1), S49-58.
16. Kontoyiannis, D. P., Lionakis, M. S., Lewis, R. E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T. J. & Raad, I. I. (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis, 191, 1350-60.
17. Latge, J. P. (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev, 12, 310-50.
18. Vandenbergh, M. F., Verweij, P. E. & Voss, A. (1999) Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environment. Diagn Microbiol Infect Dis, 34, 221-7.
19. Vonberg, R. P. & Gastmeier, P. (2006) Nosocomial aspergillosis in outbreak settings. J Hosp Infect, 63, 246-54.
20. Warnock, D. W., Hajjeh, R. A. & Lasker, B. A. (2001) Epidemiology and prevention of invasive aspergillosis. Curr Infect Dis Rep, 3, 507-16.
21. Perfect, J. R., Cox, G. M., Lee, J. Y., Kauffman, C. A., De Repentigny, L., Chapman, S. W., Morrison, V. A., Pappas, P., Hiemenz, J. W. & Stevens, D. A. (2001) The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis, 33, 1824-33.
22. Hedayati, M. T., Pasqualotto, A. C., Warn, P. A., Bowyer, P. & Denning, D. W. (2007) Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology, 153, 1677-92.
23. Burwen, D. R., Lasker, B. A., Rao, N., Durry, E., Padhye, A. A. & Jarvis, W. R. (2001) Invasive aspergillosis outbreak on a hematology-oncology ward. Infect Control Hosp Epidemiol, 22, 45-8.
24. Thio, C. L., Smith, D., Merz, W. G., Streifel, A. J., Bova, G., Gay, L., Miller, C. B. & Perl, T. M. (2000) Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol, 21, 18-23.
25. Yuen, K. Y., Woo, P. C., Ip, M. S., Liang, R. H., Chiu, E. K., Siau, H., Ho, P. L., Chen, F. F. & Chan, T. K. (1997) Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears. Clin Infect Dis, 25, 37-42.
26. Pasqualotto, A. C. (2009) Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus. Med Mycol, 47(suppl.1):S261-70.
27. Xavier, M. O., Sales Mda, P., Camargo Jde, J., Pasqualotto, A. C. & Severo, L. C. (2008) Aspergillus niger causing tracheobronchitis and invasive pulmonary aspergillosis in a lung transplant recipient: case report. Rev Soc Bras Med Trop, 41, 200-1.
28. Iwen, P. C., Rupp, M. E., Langnas, A. N., Reed, E. C. & Hinrichs, S. H. (1998) Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis, 26, 1092-7.
29. Steinbach, W. J., Benjamin, D. K., Jr., Kontoyiannis, D. P., Perfect, J. R., Lutsar, I., Marr, K. A., Lionakis, M. S., Torres, H. A., Jafri, H. & Walsh, T. J. (2004) Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis, 39, 192-8.
30. Anaissie, E. J., Stratton, S. L., Dignani, M. C., Summerbell, R. C., Rex, J. H., Monson, T. P., Spencer, T., Kasai, M., Francesconi, A. & Walsh, T. J. (2002) Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis, 34, 780-9.
31. Lass-Florl, C., Rath, P., Niederwieser, D., Kofler, G., Wurzner, R., Krezy, A. & Dierich, M. P. (2000) Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. J Hosp Infect, 46, 31-5.
32. Caston, J. J., Linares, M. J., Gallego, C., Rivero, A., Font, P., Solis, F., Casal, M. & Torre-Cisneros, J. (2007) Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi. Chest, 131, 230-6.
33. Panackal, A. A., Imhof, A., Hanley, E. W. & Marr, K. A. (2006) Aspergillus ustus infections among transplant recipients. Emerg Infect Dis, 12, 403-8.
34. Pavie, J., Lacroix, C., Hermoso, D. G., Robin, M., Ferry, C., Bergeron, A., Feuilhade, M., Dromer, F., Gluckman, E., Molina, J. M. & Ribaud, P. (2005) Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. J Clin Microbiol, 43, 4902-4.
35. Perdelli, F., Cristina, M. L., Sartini, M., Spagnolo, A. M., Dallera, M., Ottria, G., Lombardi, R., Grimaldi, M. & Orlando, P. (2006) Fungal contamination in hospital environments. Infect Control Hosp Epidemiol, 27, 44-7.
36. Schmitt, H. J., Blevins, A., Sobeck, K. & Armstrong, D. (1990) Aspergillus species from hospital air and from patients. Mycoses, 33, 539-41.
37. Arnow, P. M., Sadigh, M., Costas, C., Weil, D. & Chudy, R. (1991) Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms. J Infect Dis, 164, 998-1002.
38. Hospenthal, D. R., Kwon-Chung, K. J. & Bennett, J. E. (1998) Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol, 36, 165-8.
39. Gerson, S. L., Parker, P., Jacobs, M. R., Creger, R. & Lazarus, H. M. (1994) Aspergillosis due to carpet contamination. Infect Control Hosp Epidemiol, 15, 221-3.
40. Hahn, T., Cummings, K. M., Michalek, A. M., Lipman, B. J., Segal, B. H. & Mccarthy, P. L., Jr. (2002) Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect Control Hosp Epidemiol, 23, 525-31.
41. Sarubbi, F. A., Jr., Kopf, H. B., Wilson, M. B., Mcginnis, M. R. & Rutala, W. A. (1982) Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis, 125, 33-8.
42. Hajjeh, R. A. & Warnock, D. W. (2001) Counterpoint: invasive aspergillosis and the environment - rethinking our approach to prevention. Clin Infect Dis, 33, 1549-52.
43. Iwen, P. C., Davis, J. C., Reed, E. C., Winfield, B. A. & Hinrichs, S. H. (1994) Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect Control Hosp Epidemiol, 15, 303-6.
44. Nihtinen, A., Anttila, V. J., Richardson, M., Meri, T., Volin, L. & Ruutu, T. (2007) The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration. Bone Marrow Transplant, 40, 457-60.
45. Oren, I., Haddad, N., Finkelstein, R. & Rowe, J. M. (2001) Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol, 66, 257-62.
46. Opal, S. M., Asp, A. A., Cannady, P. B., Jr., Morse, P. L., Burton, L. J. & Hammer, P. G., II (1986) Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis, 153, 634-7.
47. Krasinski, K., Holzman, R. S., Hanna, B., Greco, M. A., Graff, M. & Bhogal, M. (1985) Nosocomial fungal infection during hospital renovation. Infect Control, 6, 278-82.
48. Pannuti, C. S., Gingrich, R. D., Pfaller, M. A. & Wenzel, R. P. (1991) Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol, 9, 77-84.
49. Haiduven, D. (2009) Nosocomial aspergillosis and building construction. Med Mycol, 47(suppl. 1):S210-6.
50. Patterson, J. E., Zidouh, A., Miniter, P., Andriole, V. T. & Patterson, T. F. (1997) Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol, 18, 104-8.
51. Anaissie, E. J. & Costa, S. F. (2001) Nosocomial aspergillosis is waterborne. Clin Infect Dis, 33, 1546-8.
52. Anaissie, E. J., Stratton, S. L., Dignani, M. C., Lee, C. K., Mahfouz, T. H., Rex, J. H., Summerbell, R. C. & Walsh, T. J. (2002) Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin Infect Dis, 35, E86-8.
53. Warris, A., Voss, A., Abrahamsen, T. G. & Verweij, P. E. (2002) Contamination of hospital water with Aspergillus fumigatus and other molds. Clin Infect Dis, 34, 1159-60.
54. Bouakline, A., Lacroix, C., Roux, N., Gangneux, J. P. & Derouin, F. (2000) Fungal contamination of food in hematology units. J Clin Microbiol, 38, 4272-3.
55. Brenier-Pinchart, M. P., Faure, O., Garban, F., Fricker-Hidalgo, H., Mallaret, M. R., Trens, A., Lebeau, B., Pelloux, H. & Grillot, R. (2006) Ten-year surveillance of fungal contamination of food within a protected haematological unit. Mycoses, 49, 421-5.
56. Marks, W. H., Florence, L., Lieberman, J., Chapman, P., Howard, D., Roberts, P. & Perkinson, D. (1996) Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation, 61, 1771-4.
57. Summerbell, R. C., Krajden, S. & Kane, J. (1989) Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia, 106, 13-22.
58. James, M. J., Lasker, B. A., Mcneil, M. M., Shelton, M., Warnock, D. W. & Reiss, E. (2000) Use of a repetitive DNA probe to type clinical and environmental isolates of Aspergillus flavus from a cluster of cutaneous infections in a neonatal intensive care unit. J Clin Microbiol, 38, 3612-8.
59. Walmsley, S., Devi, S., King, S., Schneider, R., Richardson, S. & Ford-Jones, L. (1993) Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J, 12, 673-82.
60. Pegues, D. A., Lasker, B. A., Mcneil, M. M., Hamm, P. M., Lundal, J. L. & Kubak, B. M. (2002) Cluster of cases of invasive aspergillosis in a transplant intensive care unit: evidence of person-to-person airborne transmission. Clin Infect Dis, 34, 412-6.
61. Keating, M. R., Guerrero, M. A., Daly, R. C., Walker, R. C. & Davies, S. F. (1996) Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest, 109, 1119-24.
62. Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., Wingard, J. R., Dupont, B., Rinaldi, M. G., Stevens, D. A. & Graybill, J. R. (2000) Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore), 79, 250-60.
63. Segal, B. H., Bow, E. J. & Menichetti, F. (2002) Fungal infections in nontransplant patients with hematologic malignancies. Infect Dis Clin North Am, 16, 935-64, vii.
64. Chamilos, G., Luna, M., Lewis, R. E., Bodey, G. P., Chemaly, R., Tarrand, J. J., Safdar, A., Raad, I. I. & Kontoyiannis, D. P. (2006) Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica, 91, 986-9.
65. Lortholary, O., Ascioglu, S., Moreau, P., Herbrecht, R., Marinus, A., Casassus, P., De Pauw, B. & Denning, D. W. (2000) Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the Intergroupe Francais du Myelome. Clin Infect Dis, 30, 41-6.
66. Schwartz, R. S., Mackintosh, F. R., Schrier, S. L. & Greenberg, P. L. (1984) Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer, 53, 411-9.
67. Gerson, S. L., Talbot, G. H., Hurwitz, S., Strom, B. L., Lusk, E. J. & Cassileth, P. A. (1984) Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med, 100, 345-51.
68. Burch, P. A., Karp, J. E., Merz, W. G., Kuhlman, J. E. & Fishman, E. K. (1987) Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol, 5, 1985-93.
69. Grow, W. B., Moreb, J. S., Roque, D., Manion, K., Leather, H., Reddy, V., Khan, S. A., Finiewicz, K. J., Nguyen, H., Clancy, C. J., Mehta, P. S. & Wingard, J. R. (2002) Late onset of invasive Aspergillus infection in Bone Marrow Transplant patients at a university hospital. Bone Marrow Transplant, 29, 15-9.
70. Offidani, M., Corvatta, L., Olivieri, A., Rupoli, S., Frayfer, J., Mele, A., Manso, E., Montanari, M., Centurioni, R. & Leoni, P. (1999) Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant, 24, 1079-87.
71. Morrison, V. A., Haake, R. J. & Weisdorf, D. J. (1994) Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med, 96, 497-503.
72. Wingard, J. R., Beals, S. U., Santos, G. W., Merz, W. G. & Saral, R. (1987) Aspergillus infections in Bone Marrow Transplant recipients. Bone Marrow Transplant, 2, 175-81.
73. Bensinger, W. I. & Deeg, H. J. (2000) Blood or marrow? Lancet, 355, 1199-200.
74. Fukuda, T., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Martin, P. J., Storb, R. F. & Marr, K. A. (2003) Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood, 102, 827-33.
75. Storek, J., Dawson, M. A., Storer, B., Stevens-Ayers, T., Maloney, D. G., Marr, K. A., Witherspoon, R. P., Bensinger, W., Flowers, M. E., Martin, P., Storb, R., Appelbaum, F. R. & Boeckh, M. (2001) Immune reconstitution after allogeneic marrow transplantation compared with Blood stem cell transplantation. Blood, 97, 3380-9.
76. Hagen, E. A., Stern, H., Porter, D., Duffy, K., Foley, K., Luger, S., Schuster, S. J., Stadtmauer, E. A. & Schuster, M. G. (2003) High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation. Clin Infect Dis, 36, 9-15.
77. Jantunen, E., Ruutu, P., Niskanen, L., Volin, L., Parkkali, T., Koukila-Kahkola, P. & Ruutu, T. (1997) Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant, 19, 801-8.
78. Mihu, C. N., King, E., Yossepovitch, O., Taur, Y., Jakubowski, A., Pamer, E. & Papanicolaou, G. A. (2008) Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transpl Infect Dis, 10, 162-7.
79. Marty, F. M., Lee, S. J., Fahey, M. M., Alyea, E. P., Soiffer, R. J., Antin, J. H. & Baden, L. R. (2003) Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood, 102, 2768-76.
80. Thursky, K., Byrnes, G., Grigg, A., Szer, J. & Slavin, M. (2004) Risk factors for postengraftment invasive aspergillosis in allogeneic stem cell transplantation. Bone Marrow Transplant, 34, 115-21.
81. Miyakoshi, S., Kusumi, E., Matsumura, T., Hori, A., Murashige, N., Hamaki, T., Yuji, K., Uchida, N., Masuoka, K., Wake, A., Kanda, Y., Kami, M., Tanaka, Y. & Taniguchi, S. (2007) Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases. Biol Blood Marrow Transplant, 13, 771-7.
82. Tollemar, J., Ringden, O., Bostrom, L., Nilsson, B. & Sundberg, B. (1989) Variables predicting deep fungal infections in Bone Marrow Transplant recipients. Bone Marrow Transplant, 4, 635-41.
83. Altes, A., Remacha, A. F., Sarda, P., Sancho, F. J., Sureda, A., Martino, R., Briones, J., Brunet, S., Canals, C. & Sierra, J. (2004) Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant, 34, 505-9.
84. Kontoyiannis, D. P., Chamilos, G., Lewis, R. E., Giralt, S., Cortes, J., Raad, I. I., Manning, J. T. & Han, X. (2007) Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer, 110, 1303-6.
85. Seo, K. W., Kim, D. H., Sohn, S. K., Lee, N. Y., Chang, H. H., Kim, S. W., Jeon, S. B., Baek, J. H., Kim, J. G., Suh, J. S. & Lee, K. B. (2005) Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant, 36, 1089-95.
86. Upton, A., Kirby, K. A., Carpenter, P., Boeckh, M. & Marr, K. A. (2007) Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis, 44, 531-40.
87. Vardakas, K. Z., Michalopoulos, A. & Falagas, M. E. (2005) Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a metaanalysis of randomised-controlled trials. Br J Haematol, 131, 22-8.
88. Van Burik, J. A., Ratanatharathorn, V., Stepan, D. E., Miller, C. B., Lipton, J. H., Vesole, D. H., Bunin, N., Wall, D. A., Hiemenz, J. W., Satoi, Y., Lee, J. M. & Walsh, T. J. (2004) Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis, 39, 1407-16.
89. Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y. T., Petrini, M., Hardalo, C., Suresh, R. & Angulo-Gonzalez, D. (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med, 356, 348-59.
90. Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais De Azevedo, W., Reddy, V., Boparai, N., Pedicone, L., Patino, H. & Durrant, S. (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med, 356, 335-47.
91. Wingard, J. R., Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Gersten, I. D., Mendizabal, A. M., Leather, H., Confer, D. L., Baden, L. R., Maziarz, R. T., Stadtmauer, E. A., Bolanos-Meade, J. & Brown, J. (2007) Results of a randomized, double-blind trial of fluconazole vs. voriconazole for the prevention of invasive fungal infections in 600 allogeneic blood and marrow transplant patients. In 49th ASH (The American Society of Hematology) Meeting. Atlanta, USA.
92. Kauffman, C. A. (2004) Zygomycosis: reemergence of an old pathogen. Clin Infect Dis, 39, 588-90.
93. Trifilio, S., Singhal, S., Williams, S., Frankfurt, O., Gordon, L., Evens, A., Winter, J., Tallman, M., Pi, J. & Mehta, J. (2007) Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant, 40, 451-6.